X-VAX TECHNOLOGY

x-vax-technology-logo

X-Vax Technology is a biotechnology company focused on the preclinical and clinical development of vaccines against pathogens that cause mucosal infections such as herpes, influenza, tuberculosis and HIV, affecting hundreds of millions of people around the globe. They believe that inducing antibodies that mediate the killing of infected cells will provoke an entirely new and effective immune response โ€“ so that they can finally beat these pathogens. The company was founded in 2015 and based in Jupiter, Florida.

#SimilarOrganizations #People #Financial #Website #More

X-VAX TECHNOLOGY

Social Links:

Industry:
Biotechnology Health Care Medical

Founded:
2015-01-01

Address:
Jupiter, Florida, United States

Country:
United States

Website Url:
http://www.x-vax.com

Total Employee:
11+

Status:
Active

Total Funding:
56 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Apache Wordpress Plugins


Similar Organizations

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

orig3n-logo

ORIG3N

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

rapid-novor-logo

Rapid Novor

Rapid Novor is a biotech company dedicated to advance next-generation protein sequencing technology.

soligenix-logo

Soligenix

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

vital-therapies-logo

Vital Therapies

Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.

Current Employees Featured

ulf-wiinberg_image

Ulf Wiinberg
Ulf Wiinberg President & CEO @ X-Vax Technology
President & CEO

robert-ruffolo_image

Robert Ruffolo
Robert Ruffolo Director @ X-Vax Technology
Director

not_available_image

Isaac Blech
Isaac Blech Vice Chairman @ X-Vax Technology
Vice Chairman

roger-pomerantz_image

Roger Pomerantz
Roger Pomerantz Founding Director @ X-Vax Technology
Founding Director

andreas-eggert_image

Andreas Eggert
Andreas Eggert Chief Operating Officer @ X-Vax Technology
Chief Operating Officer

clare-kahn_image

Clare Kahn
Clare Kahn Research & Preclinical Development Officer @ X-Vax Technology
Research & Preclinical Development Officer

Founder


roger-pomerantz_image

Roger Pomerantz

Investors List

johnson-johnson-innovation-jjdc_image

Johnson & Johnson Innovation โ€“ JJDC

Johnson & Johnson Innovation โ€“ JJDC investment in Series A - X-Vax Technology

founders-fund_image

Founders Fund

Founders Fund investment in Series A - X-Vax Technology

adjuvant-capital_image

Adjuvant Capital

Adjuvant Capital investment in Series A - X-Vax Technology

serum-institute-of-india-pvt-ltd_image

Serum Institute of India Pvt. Ltd.

Serum Institute of India Pvt. Ltd. investment in Series A - X-Vax Technology

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series A - X-Vax Technology

connectivity-capital_image

Connectivity Ventures Fund

Connectivity Ventures Fund investment in Series A - X-Vax Technology

helicase-venture_image

Helicase Venture

Helicase Venture investment in Series A - X-Vax Technology

thynk-capital-llc_image

Thynk Capital, LLC.

Thynk Capital, LLC. investment in Series A - X-Vax Technology

Official Site Inspections

http://www.x-vax.com Semrush global rank: 2.55 M Semrush visits lastest month: 6.91 K

  • Host name: a904c694c05102f30.awsglobalaccelerator.com
  • IP address: 76.223.54.146
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "X-Vax Technology"

X-Vax 2025 Company Profile: Valuation, Funding

X-Vax General Information Description. Operator of a biotechnology company intended to develop vaccines against pathogens acquired by a mucosal โ€ฆSee details»

X-Vax Technology Prepares to Submit IND for Genital โ€ฆ

May 19, 2021 X-Vax technology herpes vaccine . Based in Jupiter, Fla., X-Vax Technology is preparing to submit an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for its experimental herpes โ€ฆSee details»

X-Vax Technology - Funding, Financials, Valuation & Investors

X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. ... Experience the new Crunchbase, powered by AI . โ€ฆSee details»

X-Vax Technology Inc - Company Profile and News

X-Vax Technology, Inc. operates as a biotechnology company. The Company develops and commercializes therapies and vaccines against pathogens acquired by mucosal infection such โ€ฆSee details»

X-Vax Company Profile - Office Locations, Competitors, Revenue

X-Vax has 5 employees across 2 locations and $56 m in total funding,. See insights on X-Vax including office locations, competitors, revenue, financials, executives, subsidiaries and more โ€ฆSee details»

X-Vax Technology Company Information - Funding, Investors, and โ€ฆ

Get information on funding, investors, industries, and more for X-Vax Technology. See X-Vax Technology company profile and funding data.See details»

X-Vax | VentureRadar

Similar Companies: Rational Vaccines USA Privately Held We are an investigational-stage infectious disease company focused on combating all diseases resulting from herpes simplex โ€ฆSee details»

X-Vax Technology Inc. - BioCentury Company Profiles - BCIQ

Jan 20, 2022 X-Vax Technology Inc. - BioCentury Company Profiles for the biopharma industrySee details»

X-Vax Technology, Inc. | Insights

Aug 12, 2019 Already A Biomedtracker Subscriber? You have access to the full company record through your subscription.See details»

X-Vax Company Information - Funding, Investors, and More

The company X-Vax has raised a total of $56m in funding over 1 rounds. Key Insights: X-Vax Series A round, July 2019: $56m; 2019. X-Vax Series A round, July 2019 $56m. Industries. X โ€ฆSee details»

x-vax technology, inc. News & Press Releases | PR Newswire

Jul 23, 2019 Jul 21, 2021, 13:17 ET X-Vax Technology Appoints Varsha K. Jain, MD as Chief Clinical Development Officer . X-Vax Technology, Inc. (X-VAX®), a biotechnology company โ€ฆSee details»

X-Vax Technology - Tech Stack, Apps, Patents & Trademarks

Jan 13, 2025 X-VAX is a biotech company committed to developing vaccines against pathogens acquired by mucosal infection such as herpes. New. Resources. ... Experience the new โ€ฆSee details»

Beating Herpes: Inside X-VAX's Vaccine Candidate - Bioprocess โ€ฆ

May 18, 2021 The World Health Organization (WHO) reports that about half a billion people worldwideโ€”including a full 13% of those aged 15 to 49โ€”are living with genital herpes. ... X โ€ฆSee details»

Research programme: Viral vaccines - X-Vax Technology

Viral, live vaccines are being developed by X-Vax Technology for the prevention of mucosal infections, including herpes simplex virus type 1 (HSV-1) and herpes Research programme: โ€ฆSee details»

X-Vax Technology - Contacts, Employees, Board Members

Organization. X-Vax Technology . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 6. Contacts 5. โ€ฆSee details»

X-Vax Technology Inks $56M Series A - VC News Daily

X-Vax Technology (X-VAX ), a biotechnology company developing vaccines based on a new approach that mediates the killing of infected cells, today announced that it has raised $56 โ€ฆSee details»

X-Vax Technology - Products, Competitors, Financials, Employees ...

X-Vax Technology is a biotech company focused on developing vaccines against pathogens acquired by mucosal infection, specifically in the healthcare industry. The company's main โ€ฆSee details»

Elon Musk Says His AI Company Bought X at $33 Billion Valuation

2 days ago X has also integrated Grok, a chatbot developed by xAI, directly into the platform. The current iteration of the model, Grok 3, includes a search function as well as a feature โ€ฆSee details»

X-Vax | VentureRadar

Website: https://x-vax.com/ Develops vaccines targeting mucosal infection pathogens, focusing on herpes prevention using genetically deleted glycoprotein D candidate ...See details»

X-VAX TECHNOLOGY, INC. Bankruptcy Filing

Nov 22, 2023 X-VAX TECHNOLOGY, INC. filed a 7 chapter bankruptcy in the District of Delaware bankruptcy court on November 22, 2023. This is a voluntary filing; it was assigned โ€ฆSee details»

linkstock.net © 2022. All rights reserved